MedPath

To see whether Low dose magnesium sulphate can reduce haemodynamic changes associated with laryngoscopy and intubation response.

Phase 4
Registration Number
CTRI/2024/08/072007
Lead Sponsor
IMS and SUM Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Pt. belonging to ASA 1 and 2, Pt. posted for elective cases.

Exclusion Criteria

Patients belonging to ASA 3 and 4, patients who are not willing to participate in the study, patients with neurological disorder and with past psychiatric illness, patients with cardiovascular disease, patients who can’t speak or understand English,Hindi or Odia, if laryngoscopy time more than 15 secs or more than one attempt of intubation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath